The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumorsLauren L Campbell Marotta, Kornélia Polyák, Karen S. Anderson et al.|Journal of Clinical Investigation|2011Cited by 928
Signal Transducer and Activator of Transcription 3 Is Required for the Oncogenic Effects of Non–Small-Cell Lung Cancer–Associated Mutations of the Epidermal Growth Factor ReceptorJames V. Alvarez, David A. Frank|Cancer Research|2006Cited by 239
STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer PhenotypesMichael Xiang, David A. Frank|Science Signaling|2014Cited by 166
Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agentMichael Xiang, David A. Frank|Blood|2016Cited by 113
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Guillermo Peluffo et al.|Cancer Research|2022Cited by 101